COGNISION® in Clinical Trials
Advantages of COGNISION® Biomarkers
- Primary physiologic measure of the synchronous, large-scale synaptic activity underlying all brain functions
- More proximal to disease pathology and pharmacological intervention than psychometric measures
- Sensitive to many of the effects of psychotropic or acute-acting CNS compounds
- Unaffected by habituation and can be measured repeatedly without learning effects
- Sensitive measure of disease progression for monitoring chronic conditions
Practical to Operationalize in Multi-site Clinical Trials
- COGNISION® allows for testing protocols tailored to the investigational drug mechanism of action and/or cognitive deficits specific to the target population.
- COGNISION® uses advanced active electrodes that produce high quality data in any testing environment, ensuring consistent data quality across clinical study sites and reducing inter-site variability.
- COGNISION® automatically loads new protocols in real time, can quickly run additional protocols within the same system and has strong test and re-test reliability.
- COGNISION® provides automated data analysis that allows for rapid evaluation of treatment effects when needed, such as in adaptive studies.
Proven Reimbursement
- Support included
- No upfront cost
- Low monthly cost
- No long-term contract